Literature DB >> 29115453

In vivo monitoring of magnetically labeled mesenchymal stem cells homing to rabbit hepatic VX2 tumors using magnetic resonance imaging.

Yong Qin1, Lisha Zhuo2, Jinhua Cai1, Xiaoya He1, Bo Liu1, Chuan Feng1, Lin Zhang3.   

Abstract

Although mesenchymal stem cells (MSCs) have been demonstrated to possess a tumor‑homing feature, their tropism to liver tumors has not been delineated in a visible manner. The aim of the present study was to evaluate the tumor‑homing capacity of MSCs and to investigate the spatial and temporal distributions of MSCs in liver tumors using magnetic resonance imaging (MRI). MSCs were colabeled with superparamagnetic iron oxide (SPIO) particles and 4',6‑diamidino‑2‑phenylindole (DAPI), and then transplanted into rabbits with VX2 liver tumors through intravenous injections. The rabbits were subjected to MRI before and at 3, 7 and 14 days after cell transplantation using a clinical 1.5‑T MRI system. Immediately after the MRI examination, histological analyses were performed using fluorescence and Prussian blue staining. At 3 days after injection with labeled MSCs, heterogeneous hypointensity was detected on the MRI images of the tumor. At 7 days after transplantation, the tumor exhibited anisointense MRI signal, whereas a hypointense ring was detected at the border of the tumor. At 14 days after transplantation, the MRI signal recovered the hyperintensity. As demonstrated in the histological analyses, the distribution of the iron particles visualized with Prussian blue staining was consistent with the DAPI‑stained bright fluorescent nuclei, and the particles corresponded to the hypointense region on the MR images. Thus, systemically administered MSCs could localize to liver tumors with high specificity and possessed a migration feature with active tumor growth. These results demonstrated that the targeting and distribution of the magnetically labeled stem cells in the tumor could be tracked for 7 days in vivo using a clinical 1.5‑T MRI scanner.

Entities:  

Mesh:

Year:  2017        PMID: 29115453     DOI: 10.3892/mmr.2017.7902

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  MRI detection of the malignant transformation of stem cells through reporter gene expression driven by a tumor-specific promoter.

Authors:  Jun Sun; Jie Huang; Guangcheng Bao; Helin Zheng; Cui Wang; Jie Wei; Yuanqiao Fu; Jiawen Qiu; Yifan Liao; Jinhua Cai
Journal:  Stem Cell Res Ther       Date:  2021-05-12       Impact factor: 6.832

2.  Mesenchymal Stem Cells Delivery in Individuals with Different Pathologies: Multimodal Tracking, Safety and Future Applications.

Authors:  Carolina Belmar-López; Georges Vassaux; Ana Medel-Martinez; Jerome Burnet; Miguel Quintanilla; Santiago Ramón Y Cajal; Javier Hernandez-Losa; Antonio De la Vieja; Pilar Martin-Duque
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

3.  In Vitro Neural Differentiation of Bone Marrow Mesenchymal Stem Cells Carrying the FTH1 Reporter Gene and Detection with MRI.

Authors:  Tong Mu; Yong Qin; Bo Liu; Xiaoya He; Yifan Liao; Jun Sun; Jiawen Qiu; Xiaomeng Li; Yi Zhong; Jinhua Cai
Journal:  Biomed Res Int       Date:  2018-06-26       Impact factor: 3.411

Review 4.  Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy.

Authors:  Kosha J Mehta
Journal:  Stem Cell Rev Rep       Date:  2022-02-01       Impact factor: 6.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.